A panel of physicians, biotech…
A panel of physicians, biotech leaders and patient advocates took [...]
The trial was the first to assess…
The trial was the first to assess R-MDMA in patients [...]
A Chinese phase 3 trial of Bristol…
A Chinese phase 3 trial of Bristol Myers Squibb’s antibody-drug [...]
While the FDA mulls whether to…
While the FDA mulls whether to approve Protagonist Therapeutics’ hematology [...]
The federal government is pledging…
The federal government is pledging as much as $144 million [...]
After dumping its sole remaining…
After dumping its sole remaining gene therapy asset last year, [...]
Like Merck & Co.’s PAH drug…
Like Merck & Co.’s PAH drug Winrevair—which brought in $1.4 [...]
Harbour BioMed is setting sail as…
Harbour BioMed is setting sail as the Solstice begins, riding [...]
The FDA has ordered MacroGenics to…
The FDA has ordered MacroGenics to halt enrollment in a [...]
A year after Abcuro raised $200…
A year after Abcuro raised $200 million to fund a [...]